admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for...

PT381 – DMT, Hierarchies of Complexity, and Reality Switch Technologies

PharmaTher Announces FDA Orphan Drug Designation Granted to Ketamine for Prevention...

Psychedelic Bulletin #128: atai Results Disappoint; MAPS Confirmatory Phase 3 Study...

GH Research Reports Third Quarter 2022 Financial Results and Provides Business...

Legally Psychedelic: The Regulatory Environment from Oregon to Colorado

Psychedelics Weekly – Psilocybin-Assisted Psychotherapy for I.B.S., NY Aims to Legalize,...

atai Life Sciences Announces Results from Phase 2a Trial of PCN-101...

atai’s PCN-101 Candidate Fails to Meet Primary Endpoint in Heavily-Anticipated Phase...

Reunion Neuroscience Inc. Provides 2023 Corporate Update

1...979899...218 Page 98 of 218

EDITOR PICKS

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of...

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin